3 Reasons to Buy Invesco S&P 500 Equal Weight ETF Like There's No Tomorrow
Invesco S&P 500 Equal Weight ETF changes the dynamics of the S&P 500 index in an important way.
The biggest reason to buy Invesco S&P 500 Equal Weight ETF (RSP 0.47%) is contained in the exchange traded fund’s (ETF) name. That said,
» Read more about: 3 Reasons to Buy Invesco S&P 500 Equal Weight ETF Like There's No Tomorrow »
Read MoreStock Market Today: Dow, S&P 500, Nasdaq Futures Tumble—Target, Lowe's, TJX Companies Earnings In Focus
Editor’s Note: The future prices of benchmark tracking ETFs and the lede were updated in the story.
U.S. stock futures continued to decline on Wednesday following a mixed close on Monday. Futures of major benchmark indices were lower.
ITR filing decoded: How to handle capital gains from debt mutual funds after tax overhaul
The Finance Act, 2023 overhauled how capital gains from debt mutual funds are taxed, and this has made income tax return (ITR) reporting significantly more complex.
Until 31 March, 2023, gains from debt mutual funds held for over 36 months were treated as long-term capital gains (LTCG) and taxed at 20% with indexation.
Should Vanguard S&P 500 Value ETF (VOOV) Be on Your Investing Radar?
If you’re interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the Vanguard S&P 500 Value ETF (VOOV), a passively managed exchange traded fund launched on September 9, 2010.
The fund is sponsored by Vanguard. It has amassed assets over $5.65 billion,
» Read more about: Should Vanguard S&P 500 Value ETF (VOOV) Be on Your Investing Radar? »
Read MoreWith interest rates on a decline, should retail investors opt for debt mutual funds over FDs? Experts speak
Mutual Funds: Starting in February 2025, the Reserve Bank of India (RBI) began cutting the repo rate, and in three consecutive meetings – February, April, and June – the interest rates dropped by a total of 100 basis points from 6.5 to 5.5 percent in fewer than six months.
The Burst
How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read MoreThe Ivy
Is Buffett’s Favorite Stock Finally a Buy?
Berkshire Hathaway (NYSE: BRK.B) has dipped from its record highs earlier this year, and the pullback has some investors wondering: Is this the beginning of something more serious or a golden opportunity in disguise?
With shares of the B class now trading below the $490 mark, the question becomes not whether the stock is cheap in a traditional sense,
» Read more about: Is Buffett’s Favorite Stock Finally a Buy? »
Read MoreThe Spotlight
Paul Tudor Jones Just Dropped a Masterclass on How to Invest Now
Every fall, a tight-knit group of investors gathers for a friendly, but fiercely competitive, stock picking challenge. It’s hosted by Paul Tudor Jones, the legendary hedge fund manager. But it isn’t just for a good cause. The top picks from the event, backed by the likes of Bill Ackman and Stan Druckenmiller, would’ve returned 7x your money in just six months.
» Read more about: Paul Tudor Jones Just Dropped a Masterclass on How to Invest Now »